307 related articles for article (PubMed ID: 22551931)
21. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population.
Pollock-BarZiv SM; den Hollander N; Ngan BY; Kantor P; McCrindle B; West LJ; Dipchand AI
Circulation; 2007 Sep; 116(11 Suppl):I172-8. PubMed ID: 17846300
[TBL] [Abstract][Full Text] [Related]
22. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
[TBL] [Abstract][Full Text] [Related]
23. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
24. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection.
Ramsperger-Gleixner M; Spriewald BM; Tandler R; Kondruweit M; Amann K; Weyand M; Ensminger SM
Exp Clin Transplant; 2011 Dec; 9(6):387-92. PubMed ID: 22142046
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
[TBL] [Abstract][Full Text] [Related]
26. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
[TBL] [Abstract][Full Text] [Related]
27. Alteration of Cardiac Deformation in Acute Rejection in Pediatric Heart Transplant Recipients.
Chanana N; Van Dorn CS; Everitt MD; Weng HY; Miller DV; Menon SC
Pediatr Cardiol; 2017 Apr; 38(4):691-699. PubMed ID: 28161809
[TBL] [Abstract][Full Text] [Related]
28. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
[TBL] [Abstract][Full Text] [Related]
29. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation.
Orrego CM; Cordero-Reyes AM; Estep JD; Loebe M; Torre-Amione G
J Heart Lung Transplant; 2012 Aug; 31(8):845-9. PubMed ID: 22609184
[TBL] [Abstract][Full Text] [Related]
31. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
32. Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations.
Kfoury AG; Miller DV; Snow GL; Afshar K; Stehlik J; Drakos SG; Budge D; Fang JC; Revelo MP; Alharethi RA; Gilbert EM; Caine WT; McKellar S; Molina KM; Hammond MEH
J Heart Lung Transplant; 2016 Mar; 35(3):335-341. PubMed ID: 26586489
[TBL] [Abstract][Full Text] [Related]
33. Endomyocardial biopsy in heart transplantation: schedule or event?
Chi NH; Chou NK; Tsao CI; Huang SC; Wu IH; Yu HY; Chen YS; Wang SS
Transplant Proc; 2012 May; 44(4):894-6. PubMed ID: 22564577
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
36. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
37. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
[TBL] [Abstract][Full Text] [Related]
38. The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children.
Ware AL; Malmberg E; Delgado JC; Hammond ME; Miller DV; Stehlik J; Kfoury A; Revelo MP; Eckhauser A; Everitt MD
J Heart Lung Transplant; 2016 Feb; 35(2):179-85. PubMed ID: 26520246
[TBL] [Abstract][Full Text] [Related]
39. Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?
Revelo MP; Stehlik J; Miller D; Snow GL; Everitt MD; Budge D; Bader FM; Alharethi RA; Gilbert EM; Reid BB; Selzman CH; Hammond ME; Kfoury AG
J Heart Lung Transplant; 2011 Feb; 30(2):144-50. PubMed ID: 20855221
[TBL] [Abstract][Full Text] [Related]
40. Pathological antibody-mediated rejection in pediatric heart transplant recipients: Immunologic risk factors, hemodynamic significance, and outcomes.
Hollander SA; Peng DM; Mills M; Berry GJ; Fedrigo M; McElhinney DB; Almond CS; Rosenthal DN
Pediatr Transplant; 2018 Aug; 22(5):e13197. PubMed ID: 29729067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
